CXCR2 and breast cancer: Additionally, the phenomenon that CXCR2 depletion increases p53 expression and alleviates p21 expression in MCF-7hPTTG1 cells provides a possible explanation for why breast cancers with poor prognosis demonstrate increased p53 expression but a loss of p21 expression [40].